GCC Regulatory Affairs Pharma Summit 2023: Shaping the Future of Healthcare

The 10th GCC Regulatory Affairs Pharma Summit in Dubai successfully gathered over 650 professionals, discussing the evolution of pharmaceutical regulations. Key speeches and training sessions highlighted the event, fostering regional collaboration and enhancing regulatory compliance to drive innovation in the healthcare sector.

The much-anticipated 10th edition of the GCC Regulatory Affairs Pharma Summit recently wrapped up in Dubai at the esteemed Movenpick Grand Al Bustan, attracting over 650 experts, including government officials and industry leaders. The summit, held from February 17-21, delved into critical regulatory topics, drug safety, and procurement strategies.

In her keynote address, Dr. Ruqaya Al Bastaki of the Emirates Drug Establishment emphasized the redefining regulatory landscape in the UAE. Meanwhile, Dr. Mona Al Moussli and Dr. Najiba Al Shezawy highlighted the importance of such forums for navigating regulatory updates and driving healthcare innovation across the region.

Significant participation from regulatory bodies, including the Ministry of Health entities from across the GCC and beyond, underscored the summit's role as a premier gathering for regulatory affairs professionals. The event successfully fostered dialogue, insights, and networking, reinforcing its stature as a transformative platform in the pharmaceutical sector.

(With inputs from agencies.)